Page 2 - Zyme Communications News Today

Mersey Care NHS Foundation Trust and the University of Liverpool recently established M-RIC as part of the UK Government's national 'Mental Health Mission' Pangaea's novel Artificial Intelligence

New branding reflects customer-centric approach and showcases pioneering, single cell analysis technology Rebrand follows a period of significant growth for the Company, including key leadership

First delivery and use of DNA manufactured using Evonetix's unique thermally controlled synthesis technology Key milestone in the development of Evonetix's desktop DNA synthesis platform EVONETIX

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples Gyros Protein Technologies AB, a leading provider of peptide synthesizers and

3DSecret funded by European Innovation Council's Pathfinder Open 2022, established under the EU Horizon Europe program Consortium to leverage novel microfluidic technology to culture 3D cancer

Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights

Memorial Sloan Kettering Cancer Center and Fred Hutch Cancer Center now open for patient enrolment to pre|CISION lead programme, AVA6000 Avacta Group plc (AIM: AVCT), a life sciences company developing

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute Syncona and Cambridge

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute ... | April 4, 2023

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announced the appointment of Karen Harrison as Chief Operating Officer